Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
COT
Cotinga Pharmaceuticals Inc. (COT.V)
C$0.04
-41.7%
C$0.03
C$0.02
C$0.12
C$770KN/A20,281 shs1,000 shs
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
C$0.01
C$0.01
C$0.01
C$0.02
C$1.85MN/A317,764 shs26,000 shs
PBS
Invesco Next Gen Media and Gaming ETF
$60.41
+0.1%
$55.89
$30.95
$40.10
$30.07M1.225,287 shs5,961 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
COT
Cotinga Pharmaceuticals Inc. (COT.V)
0.00%0.00%0.00%0.00%0.00%
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
0.00%0.00%0.00%0.00%0.00%
PBS
Invesco Next Gen Media and Gaming ETF
-0.52%+1.29%+8.14%+26.88%+26.19%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/AN/AN/AN/AN/AN/AN/AN/A
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/AN/AN/AN/AN/AN/AN/AN/A
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
COT
Cotinga Pharmaceuticals Inc. (COT.V)
0.00
N/AN/AN/A
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
0.00
N/AN/AN/A
PBS
Invesco Next Gen Media and Gaming ETF
2.71
Moderate Buy$60.41N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/AN/AC$0.00 per share17.50C($0.18) per shareN/A
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
C$2.23M0.83C$0.00 per share10.00C($0.07) per share-0.15
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/A-C$0.12N/AN/AN/AN/AN/AN/A
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/A-C$0.01N/AN/AN/AN/AN/AN/A
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/A30.67N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
COT
Cotinga Pharmaceuticals Inc. (COT.V)
C$0.24685.71%N/AN/A N/A
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/AN/AN/AN/AN/A
PBS
Invesco Next Gen Media and Gaming ETF
$1.011.67%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/A
0.05
0.01
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
N/A
0.04
0.03
PBS
Invesco Next Gen Media and Gaming ETF
N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
COT
Cotinga Pharmaceuticals Inc. (COT.V)
N/A21.99 millionN/ANot Optionable
Medifocus Inc. (MFS.V) stock logo
MFS
Medifocus Inc. (MFS.V)
4,800184.98 millionN/ANot Optionable
PBS
Invesco Next Gen Media and Gaming ETF
N/A910,000N/ANot Optionable

Recent News About These Companies

Invesco Next Gen Media and Gaming ETF
IGPT Invesco AI and Next Gen Software ETF
"Barbie" Hits $1B at Box Office: Media ETFs on a Roll
Media Stocks & ETFs in Focus on "Barbenheimer"s Success
ETFs to Add Gains on Netflix Q2 Solid Subscriber Growth
These 2 Invesco ETFs Offer Meta Exposure
Invesco Dynamic Media PBS Trading Report
Netflix Returns to Growth, Shares Spike: ETFs to Tap
Disney Subscriber Base Overtakes Netflix: 5 ETFs to Stream
Which ETF will benefit most if Elon Musk buys Twitter?

Cotinga Pharmaceuticals Inc. (COT.V) CVE:COT

C$0.04 -0.03 (-41.67%)
As of 10/14/2020

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

Medifocus Inc. (MFS.V) stock logo

Medifocus Inc. (MFS.V) CVE:MFS

C$0.01 0.00 (0.00%)
As of 09/4/2020

Medifocus, Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus, Inc. is based in Toronto, Canada.

Invesco Next Gen Media and Gaming ETF NYSEARCA:PBS

$60.41 +0.07 (+0.11%)
As of 07/2/2025

PowerShares Dynamic Media Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Media Intellidex Index (the Index). The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States media companies. These are companies that are principally engaged in the development, production, sale and distribution of goods or services used in the media industry. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.